Clinical Trial Update: Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating rivaroxaban for efficacy and safety in acute non-neoplastic portal vein thrombosis in compensated cirrhosis; current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Portal Vein Thrombosis

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Portal Vein Thrombosis | Phase 3 | Status: UNKNOWN